Microsoft Word 侯东园_new_.doc

Similar documents
H 2 SO ml ml 1. 0 ml C 4. 0 ml - 30 min 490 nm 0 ~ 100 μg /ml Zhao = VρN 100% 1 m V ml ρ g

林学 园艺

380 研 究 论 文 发 酵 天 数 双 乙 酰 测 定 : 参 照 GB 标 准 发 酵 液 中 的 化 学 成 分 的 测 定 : 采 用 GC-8A 型 气 相 色 谱 测 定 1.5 离 子 注 入 方 法 [6] 把 待 处 理 的 菌 株 细 胞 均 匀 涂

, Vol.34, No.21 nm nm nm nm μm μm μm a b c d e

L 8 0 g L ~0 700 g L % 6 00% 1 50% 1 3 NaCl 0 50% NH 4 2 SO % KH 2 PO % CaCO % 0 03% ~ 0 04% 2 24 h 0 02

SWAN min TITAN Thunder Identification Tracking Analysis SWAN TITAN and Nowcasting 19 TREC Tracking Radar Echo by Correlaction T

Microsoft Word 李海波_new_.doc

: 307, [], [2],,,, [3] (Response Surface Methodology, RSA),,, [4,5] Design-Expert 6.0,,,, [6] VPJ33 ph 3,, ph, OD, Design-Expert 6.0 Box-Behnken, VPJ3

DOI /j.issn Food Research And Development UPLC-MS/MS 5 0.

~ a 3 h NCEP ~ 24 3 ~ ~ 8 9 ~ km m ~ 500 m 500 ~ 800 m 800 ~ m a 200

TGF-β AngⅡ B SD ~ 220g SPF. SCXK No SYXK ~ 25 40% ~ 70% OR37G-C

相 对 校 正 因 子 的 相 关 方 法 1.1 内 标 多 控 法 研 究 发 现, 在 中 药 各 成 分 间 存 在 着 一 定 的 比 例 关 系, 只 要 各 成 分 的 量 符 合 该 比 例 关 系, 中 药 的 多 [6] 指 标 质 量 控 制 可 以 依 此 法

Microsoft Word - 4期中文目次.doc

[1-3] (Smile) [4] 808 nm (CW) W 1 50% 1 W 1 W Fig.1 Thermal design of semiconductor laser vertical stack ; Ansys 20 bar ; bar 2 25 Fig

/MPa / kg m - 3 /MPa /MPa 2. 1E ~ 56 ANSYS 6 Hz (a) 一阶垂向弯曲 (b) 一阶侧向弯曲 (c) 一阶扭转 (d) 二阶侧向弯曲 (e) 二阶垂向弯曲 (f) 弯扭组合 2 6 Hz

Ansys /4 Ansys % 9 60% MU10 M m 1 Fig. Actual situation of measured building 1 Fig. 1 First floor plan of typical r

基 础 研 究 食 品 科 学 2011, Vol. 32, No 白 球 蛋 白 醇 溶 蛋 白 和 碱 溶 蛋 白 等, 发 现 白 果 中 的 蛋 白 质 主 要 以 清 蛋 白 和 球 蛋 白 为 主, 其 中 白 果 清 蛋 白 具 有 抗 氧 化 和 延 缓 衰 老 等 作

Microsoft Word - 22 栗志民.doc

404 中 草 药 Chinese Traditional and Herbal Drugs 第 42 卷 第 2 期 2011 年 2 月 加 入 的 十 二 烷 基 磺 酸 钠 活 性 剂 1.23 g, 在 球 磨 机 转 速 600 r/min 的 条 件 下 球 磨 8 h, 所 得 粉

Microsoft Word tb 赵宏宇s-高校教改纵横.doc

PCA+LDA 14 1 PEN mL mL mL 16 DJX-AB DJ X AB DJ2 -YS % PEN

< F63756D656E D2D796E2D31C6DABFAF2D31D6D0D2BDD2A9CFD6B4FABBAF2D C4EA2DB5DA34C6DA2DC4BFC2BC2D34C6DA2E6D6469>

% 8. 48% 3 80 Alcalase Novozymes Alcalase 2. 4 L Bacillus licheniformis 2. 4 AU /g 1. 2 Hitachi S-4700 JEOL JEM-1200EX Olympus Bu

2 : 111 ( Pinctada maxima), 13, 11,,,,,, 15, 25 cm, cm, 4 5 kg 1-2],,, 3-7] 24] 25-26],,, ] min, 1, 5 m 4 m, 20 m , 9-22],,, (

助 剂 改 善 其 止 血 效 果 1 实 验 1.1 原 料 和 试 剂 家 蚕 蛹 经 过 提 取 蛹 油 蛋 白 质 后 剩 余 的 残 渣 ( 主 要 成 分 为 蛹 皮 ), 烘 干 除 杂 粉 碎 后 待 用 ; 壳 聚 糖 ( 成 都 市 科 龙 化 工 试 剂 厂 ), 脱 乙 酰

892311B009006

JOURNAL OF EARTHQUAKE ENGINEERING AND ENGINEERING VIBRATION Vol. 31 No. 5 Oct /35 TU3521 P315.

1.0 % 0.25 % 85μm % U416 Sulfate expansion deformation law and mechanism of cement stabilized macadam base of saline areas in Xinjiang Song

activities than commercial antibacterial agents. Moreover, "Extract Cleanser was safe to organisms as the result of toxicity evaluation identified by

<443A5CC2DBCEC45CB5DAD2BBC6DA5C3036D7DBCAF65CD2BBC6DA2DD7DBCAF6>

% 6 9 [1] % 97% [2] 2 93% 3 4,, 2

5-25袁宏钧.indd

by industrial structure evolution from 1952 to 2007 and its influence effect was first acceleration and then deceleration second the effects of indust

296 FINE CHEMICALS 33 Sinensis Lam extracts = system systemⅢ performed best. Key words natural surfacetant Camellia Oleifera Abel meal Sap

Microsoft Word 曹伏君_new_.doc

Microsoft Word - molecules supple.docx

4期

Microsoft Word - 1--齐继峰_new_.doc

s 15 contact s W Si 3 N μm N / m 4 AFM 95% AFM WPOJ UPOJ WPOJ UPOJ 260 ~ 280 nm WPOJ-DS UPOJ-DS 1 cm 1 cm DEAE-ce

untitled

Fig. 1 1 The sketch for forced lead shear damper mm 45 mm 4 mm 200 mm 25 mm 2 mm mm Table 2 The energy dissip

Jounal of Chinese Medicinal Mateials ml 10 ml 70% O G S G 70% mg /ml

Microsoft Word 蔡伟江-二校

食品 营养 检测 安全

~ 4 mm h 8 60 min 1 10 min N min 8. 7% min 2 9 Tab. 1 1 Test result of modified

<4D F736F F D C4EAD4BAD6D8B5E3CAB5D1E9CAD2C4EAB1A8B1E0D0B4CCE1B8D95FBBB7BEB3D3EBD3A6D3C3CEA2C9FACEEFD6D8B5E3CAB5D1E9CAD25F2E646F74>

2001,30(1):1-4

Microsoft Word - A _ doc

< F63756D656E D2D796E2D31C6DABFAF2D31D6D0D2BDD2A9CFD6B4FABBAF2D C4EA2DB5DA36C6DA2DB7E2C3E6CDC6BDE9A3A D36A3A92E6D6469>

Microsoft Word - 11-秦华伟.doc

Microsoft Word 叶然_new_.doc

一 概 述 ( 一 ) 兽 药 和 兽 药 残 留 的 概 念 掌 握 典 型 的 兽 药 : 是 指 用 于 预 防 和 治 疗 畜 禽 疾 病 的 药 物 但 是, 随 着 集 约 化 养 殖 生 产 的 开 展, 一 些 化 学 的 生 物 的 药 用 成 分 被 开 发 成 具 有 某 些

12-1b T Q235B ML15 Ca OH Table 1 Chemical composition of specimens % C Si Mn S P Cr Ni Fe

<30302DB7E2C3E6CDC6BDE9A3A D32A3A92E4D4449>

240 生 异 性 相 吸 的 异 性 效 应 [6] 虽 然, 心 理 学 基 础 研 [7-8] 究 已 经 证 实 存 在 异 性 相 吸 异 性 相 吸 是 否 存 在 于 名 字 认 知 识 别 尚 无 报 道 本 实 验 选 取 不 同 性 别 的 名 字 作 为 刺 激 材 料, 通

Supporting_Information_revise

Vol. 22 No. 4 JOURNAL OF HARBIN UNIVERSITY OF SCIENCE AND TECHNOLOGY Aug GPS,,, : km, 2. 51, , ; ; ; ; DOI: 10.

[1] Nielsen [2]. Richardson [3] Baldock [4] 0.22 mm 0.32 mm Richardson Zaki. [5-6] mm [7] 1 mm. [8] [9] 5 mm 50 mm [10] [11] [12] -- 40% 50%

材 料 与 方 法 仪 器 ACQUITY UPLC Xevo TQ-S 三 重 四 级 杆 液 质 联 用 仪 ( 美 国 Waters 公 司 ); 电 喷 雾 离 子 源 (ESI), Masslynx 4.1 数 据 处 理 系 统 (Waters);Thermo 低 温 离 心 机 ;KQ


Microsoft Word - A doc

32期

标题

GB 15973—1995麻风病诊断标准及处理原则

SVM OA 1 SVM MLP Tab 1 1 Drug feature data quantization table

5期xin

mm 400 mm 15 mm EOF mm/10a Fig. 1 Distributions

Mnq 1 1 m ANSYS BEAM44 E0 E18 E0' Y Z E18' X Y Z ANSYS C64K C70C70H C /t /t /t /mm /mm /mm C64K

Microsoft Word _editing


LaDefense Arch Petronas Towers 2009 CCTV MOMA Newmark Hahn Liu 8 Heredia - Zavoni Barranco 9 Heredia - Zavoni Leyva

Microsoft Word - 8 期中文目次.doc

2012年18期

ph ph ph Langmuir mg /g Al 2 O 3 ph 7. 0 ~ 9. 0 ph HCO - 3 CO 2-3 PO mg /L 5 p

资源 环境 生态 土壤 气象

untitled

卫生检验学实习指导.doc

中 草 药 Chinese Traditional and Herbal Drugs 第 46 卷 第 9 期 2015 年 5 月 1339 非 酒 精 性 脂 肪 性 肝 病 (nonalcoholic fatty liver disease,nafld) 是 一 种 与 胰 岛 素 抵 抗 遗

Microsoft Word 定版

1 GIS 95 Y = F y + (1 F) (1) 0 0 Y0 kg/hm 2 /day F y 0 y c kg/hm 2 /day [12] y m 20 kg/hm 2 /hour Y = cl cn ch G [ F( y ) T m yo + (2) (1 F)(

2月5期aa

9期

22期xin

Technical Acoustics Vol.27, No.4 Aug., 2008,,, (, ) :,,,,,, : ; ; : TB535;U : A : (2008) Noise and vibr

31 17 www. watergasheat. com km 2 17 km 15 km hm % mm Fig. 1 Technical route of p

10 中 草 药 Chinese Traditional and Herbal Drugs 第 43 卷 第 1 期 2012 年 1 月 生 药 打 粉 入 药 的 基 本 特 点, 借 鉴 材 料 学 粉 体 学 等 学 科 的 研 究 成 果, 在 中 药 传 统 制 药 理 念 的 启 发

<453A5CCAB3C6B7BFC6D1A73131C4EA3134C6DA5C3134C6DA5C3032B7D6CEF6>

第二部分

中 草 药 Chinese Traditional and Herbal Drugs 第 5 卷 第 1 期 201 年 1 月 51 其 他 试 剂 均 为 分 析 纯 对 照 品 栀 子 苷 ( 批 号 ) 甘 草 苷 ( 批 号 ) 连 翘 酯 苷

% GIS / / Fig. 1 Characteristics of flood disaster variation in suburbs of Shang

标题

2012 年度中国科技核心期刊目录 CODE F034 ACTA BIOCHIMICA ET BIOPHYSICA SINICA C096 ACTA MATHEMATICA SCIENTIA B030 ACTA MATHEMATICA SINICA ENGLISH SERIES I051 ACTA

Microsoft Word _editing

Vol. 15 No. 1 JOURNAL OF HARBIN UNIVERSITY OF SCIENCE AND TECHNOLOGY Feb O21 A

36期

The frame research on the management system of Chinese herbal medicine A Dissertation Submitted for the Master s Degree Candidate:Han Feng Tutor: Prof

Microsoft Word 刘秀秀_new_.doc

(),,,,;, , (Π, ), , , 5162 %, U , ,,1992, , : ;

标题

Microsoft Word - Supporting Information clear

Transcription:

46 5 Vol.46, No.5 2015 9 OCEANOLOGIA ET LIMNOLOGIA SINICA Sep., 2015 (Bacillus amyloliquefacien) Macrolactin A * ( 315211) (Bacillus amyloliquefaciens)esb-2 Macrolactin A,,, Macrolactin A Macrolactin A, : Macrolactin A, 95%, ; Macrolactin A,, 1%, 18.5mg/L, 2 Macrolactin A ; ; Macrolactin A; Q936 doi: 10.11693/hyhz20141200363 (Tulp et al, 2004),, (Haefner, 2003;, 2006) Macrolactin Scripps Fenical 24 (He et al, 2012b), 19 (Gustafson et al, 1989; Jaruchoktaweechai et al, 2000) Macrolatin A 24, 1 Macrolactin A, B16-F10, Macrolactin A (Herpes simplex) HIV T (Kim et al, 1997;, 2008), Macrolactin A,,,,, Macrolatin A,, Macrolactin (Bacillus amyloliquefaciens) ESB-2 (He et al, 2012a), Macrolatin A,, Macrolatin A (He et al, 2012a), Macrolactin A (Yang et al, 2009),, (Kim et al, 2005) Macrolactin A ; (high speed countercurrent chromatography, HSCCC) *, 41306134,, E-mail: linhoudy@163.com :,,,, E-mail: wuzufang@nbu.edu.cn : 2014-12-30, : 2015-03-09

1072 46 (Ito, 1991),, (Owen et al, 1997; Li et al, 2001), (, 2003), (Dalhoff et al, 2003; Nishivama et al, 2000) Macrolactin A,,,, Macrolactin A, 1 Macrolactin A Fig.1 The chemical structure of Macrolactin A 1 1.1 1.1.1 (Bacillus amyloliquefaciens)esb-2, 1.1.2 2216E, 5.0g 1.0g 15.0g 35.0g 0.1g 1000mL, ESB-2 ;, 5.0g 1.0g 35.0g 0.1g 1000mL, ESB-2 121 C, 1 10 5 Pa 20min 1.1.3 : TAUTO HSCCC-TBE300B (, 2.6mm, 280mL, 20mL), SHP DC-0506, AKTAprime plus, ; Waters e2695, YMC- Pack ODS-A(150 mm 4.6 mm, 5 μm), Waters ; SPX, ; GL- 21MC, ; UV-3300 ; LDZX-50KBS, ; SW-CJ-2D ; HGC-12D ; PHS-3C ph ; RE-52C (, CNW ), ADS-30, (, ) 1.2 1.2.1 ESB-2 24h, 100mL 250mL,, 30 C 150r/min 24h,, 5%,, 30 C 150r/min 48h, 1.2.2 Macrolactin A,, 45 C, 1mL, 12000r/min 15min, 1.2.3 8, 1%,, 1.2.4 1%,, 5%, 40%, 30 C, 150r/min, 48h,,,, 0. 45μm, HPLC Macrolactin A, Macrolactin A 1.2.5 Macrolactin A Macrolactin A : 30L, (8000 r/min, 10min) ADS-30,,,,,,, Macrolactin A, : V( ) : V( ) : V( ).. V( ) 4.. 3.. 4.. 3, ;,, 20 min ; [ V( ) : V( ) = 1.. 1 ]

5 : (Bacillus amyloliquefacien) Macrolactin A 1073 (, 2010), 30mL/min,, 800 r/min, 10mL/min, 280nm, : HPLC, YMC-Pack ODS-A (150 mm 4.6 mm, 5 μm), 280nm, 30 C, ; 60min 10% 90%, 10min, 0.8mL/min, 10μL 1.2.6 Macrolactin A,, 1mg/mL, 0.2 0.04 0.008mg/L,, : Macrolactin A, YMC-Pack ODS-A (150 mm 4.6 mm, 5 μm), 280nm, 30 C, (A) : (B) ; 60min (A) 10% 90%, 0.8mL/min, 10μL 1.2.7 ph (, 2014), ESB-2 5%,,, 2h 5mL OD ; ph ph; 2 2.1 Macrolactin A 2.1.1 Macrolactin A HSCCC V( ) : V( ) : V( ) : V( ) 4.. 3.. 4.. 3, 1.2.5, 10mL, HSCCC, HSCCC ( 2), 48%, HPLC, HPLC A Macrolactin A, HPLC, 95.8%, HPLC 3 2 Macrolactin A HSCCC Fig.2 HSCCC chromatogram of the crude extract of Macrolactin A 3 HSCCC Macrolactin A (a) (b) Fig.3 HPLC and UV of Macrolactin A by HSCCC ADS-30,,, 23% HSCCC, HSCCC, HSCCC,, 30s; K 0.5<K<2 (Cao et al, 2011) - - - HSCCC, 48%, 350mg, HSCCC Macrolactin A 50.4mg,,, HSCCC 2.1.2 Macrolactin A 1mg/mL, 0.2 0.04 0.008mg/L,

1074 46, Macrolactin A Y=2.9E+6X 33234, R 2 =0.998,,, (, 2013) 2.2 2.2.1 ESB-2, 1%,, 30 C, 24h ( 4), 2216E,, Fig.4 4 ESB-2 Effect of carbon sourceon thenumber of totalcolony of ESB-2,,,, ESB-2,, Macrolactin A 2.2.2 ESB-2 Macrolactin A, 7, 1% (W/V),,, Macrolactin A 1 1, Macrolactin A,,, Macrolactin A Macrolactin A (, 2010), (, 2011);,,, Macrolactin A 2216E, SAS,,,,, 表 1 碳源对 ESB-2 菌株生物量及 Macrolactin A 产量的影响 Tab.1 Effects of carbon source on biomass and Macrolactin A production by ESB-2 ph (10 8 cfu/ml) Macrolactin A (mg/l) 8.59 10.5±1.0 e* 9.034±0.451 d Glucose 5.91 3.00±0.50 d 17.643±0.131 b Maltose 5.62 46.66±1.80 b 18.816±0.220 a Lactos 7.16 39.33±3.11 c 5.095±0.110 de Starch 6.32 55.67±5.17 a 9.322±0.153 d α-cyclodextrin 8.58 10.50±1.32 e 0.665±0.114 f Sucrose 5.96 7.00±1.32 ef 15.788±0.321 c Glycerol 4.45 3.67±0.57 f 1.545±0.211 e * ±, SAS (P<0.05)

5 : (Bacillus amyloliquefacien) Macrolactin A 1075 2.2.3 Macrolactin A (5 10 20 30 40 g/l),, Macrolactin A, 5 5, Macrolactin A,,, 10 g/l, MA, 10 g/l, Macrolactin A, 10 g/l, Macrolactin A, 18.816 g/l, 2.08,, 1% 5 Macrolactin A Fig.5 Effects of maltose concentration on Macrolactin A production, Macrolactin A,, Macrolactin A,, Macrolactin A,,, (, 2013) 2.2.4, ESB-2 (0 48h), 6,, ph,, 0 12h,,, Macrolactin A, ph 12 24h,, ph,, Macrolactin A 24 48h, ph,,, (, 2008), 24h,, (, 2013),,,, Fig 6 6 ESB-2 The fermentation curves of shaking flask culture

1076 46 3,, ADS-30 Macrolactin A, 95.8%,,, ESB-2,, 1%, 2d 18.82 mg/l, 2, Macrolactin A 7d,, Macrolactin A 3.5,,,,, 2006.., 8(4): 1 4,,, 2013. (Bacillus amyloliquefaciens) Macrolactin B., 44(6): 1592 1596, 2010.. :, 2013.. :,,, 2008. β-., 36(10): 66 70,, 2003.., 18(6): 282 283,,, 2013.., 34(14): 57 62,,, 2014.., 20(5): 817 824, 2011.. :,,, 2010.., 28(1): 68 72,,, 2008. Macrolactins X-2 PKS., 35(9): 1367 1372 Cao X L, Wang Q E, Li Y et al, 2011. Isolation and purification of series bioactive components from Hypericum perforatum L. by counter-current chromatography. Journal of Chromatography B, 879(7 8): 480 488 Dalhoff A, Nasu T, Okamoto K, 2003. Beta-lactamase stability of faropenem. Chemotherapy, 49(5): 229 236 Gustafson K, Roman M, Fenical W, 1989. The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium. Journal of the American Chemical Society, 111(19): 7519 7524 Haefner B, 2003. Drugs from the deep: marine natural products as drug candidates. Drug Discovery Today, 8(12): 536 544 He S, Wang H Q, Wu B et al, 2012a. Response surface methodology optimization of fermentation conditions for rapid and efficient accumulation of macrolactin a by marine Bacillus amyloliquefaciens ESB-2. Molecules, 18(1): 408 417 He S, Wang H Q, Yan X J et al, 2012b. Preparative isolation and purification of macrolactin antibiotics from marine bacterium Bacillus amyloliquefaciens using high-speed counter-current chromatography in stepwise elution mode. Journal of Chromatography A, 1272: 15 19 Ito Y, 1991. Recent advances in counter-current chromatography. Journal of Chromatography A, 538(1): 3 25 Jaruchoktaweechai C, Suwanborirux K, Tanasupawatt S et al, 2000. New macrolactins from a marine Bacillus sp. Sc026. Journal of Natural Products, 63(7): 984 986 Kim H-H, Hwang S-Y, Kim W-G et al, 1997. Neuronal cell protection activity of macrolactin A produced by Actinomadura sp.. Journal of Microbiology and Biotechnology, 7(6): 429 434 Kim H O, Lim J M, Joo J H et al, 2005. Optimization of submerged culture condition for the production of mycelial biomass and exopolysaccharides by Agrocybe cylindracea. Bioresource Technology, 96(10): 1175 1182 Li H B, Chen F, 2001. Preparative isolation and purification of six diterpenoids from the Chinese medicinal plant Salvia miltiorrhiza by high-speed counter-current chromatography. Journal of Chromatography A, 925(1 2): 109 114 Nishivama T, Matsuzaki K, Kovama H et al, 2000. In vitro activity of faropenem against beta-lactamase producing clinical isolates. The Japanese Journal of Antibiotics, 53(3): 179 183 Owen R O, McCreath G E, Chase H A, 1997. A new approach to continuous counter-current protein chromatography: Direct purification of malate dehydrogenase from a Saccharomyces cerevisiae homogenate as a model system. Biotechnology and Bioengineering, 53(4): 427 441 Tulp M, Bohlin L, 2004. Unconventional natural sources for future drug discovery. Drug Discovery Today, 9(10): 450 458 Yang Q, Han W J, Zhang W J et al, 2009.Identification of a macrolactina antibiotic-producing marine Bacillus amyloliquefaciens JY-863 strain and optimization of its fermentation conditions. Pharmaceutical Biotechnology, 16(4): 311 315, 346

5 : (Bacillus amyloliquefacien) Macrolactin A 1077 OPTIMIZATION OF CARBON RESOURCE FOR MACROLACTIN A PRODUCTION FROM MARINE BACILLUS AMYLOLIQUEFACIEN HOU Dong-Yuan, WU Zu-Fang, ZHANG Xin (Ningbo University, Key Laboratory of Applied Marine Biotechnology of Ministry of Education, Ningbo 315211, China) Abstract To optimize the production of Macrolactin A from a marine Bacillus amyloliquefaciens ESB-2, we extract crude material with macroporous adsorptive resin and then purified in high-speed counter-current chromatography (HSCCC). The purity of separated component was determined and the influence of different carbon sources on Macrolactin A yield was detected, in high performance liquid chromatography (HPLC). The fermentation curve of marine Bacillus amyloliquefaciens was obtained under optimization condition. The results show that Macrolactin A could be purified quickly in HSCCC, and the purity of the product reached >95%. The carbon sources of glucose, sucrose, and maltose were conducive for the accumulation of Macrolactin A, and maltose was the best carbon source at concentration of 1%, under which the concentration of Macrolactin A could reach 18.5 mg/l and the production was more than doubled. Key words high-speed counter-current chromatography (HSCCC); Bacillus amyloliquefaciens; Macrolactin A; carbon resource optimization